Evidence map›Paper›PMID 40362579›Full record

ArticleInternational journal of molecular sciences2025

Molecular Dynamics Simulations of the SPRED2

Martina Terrusa, Elisa Sangiovanni, Marialetizia Motta, Marco Tartaglia, Ingrid Guarnetti Prandi, Giovanni Chillemi

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Martina TerrusaDepartment for Innovation in Biological, Agro-Food and Forest Systems-DIBAF, University of Tuscia, Via S. Camillo de Lellis s.n.c, 01100 Viterbo, Italy.
Elisa SangiovanniDepartment for Innovation in Biological, Agro-Food and Forest Systems-DIBAF, University of Tuscia, Via S. Camillo de Lellis s.n.c, 01100 Viterbo, Italy.
Marialetizia MottaMolecular Genetics and Functional Genomics, Bambino Gesù Children's Hospital IRCCS, 00146 Rome, Italy.
Marco TartagliaMolecular Genetics and Functional Genomics, Bambino Gesù Children's Hospital IRCCS, 00146 Rome, Italy.ORCID 0000-0001-7736-9672
Ingrid Guarnetti PrandiDepartment for Innovation in Biological, Agro-Food and Forest Systems-DIBAF, University of Tuscia, Via S. Camillo de Lellis s.n.c, 01100 Viterbo, Italy.
Giovanni ChillemiDepartment of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.

Funding

Associazione Italiana per la Ricerca su Cancro IG 28768
6 · The paper itself

Abstract

The homozygous Leu100Pro amino acid substitution in SPRED2, a protein negatively controlling RAS function, has recently been identified to be causally linked to a recessive form of Noonan syndrome. The amino acid substitution was documented to affect protein stability and cause a decreased and/or less stable interaction with neurofibromin, a RAS-specific GTPase activating protein negatively regulating RAS function. To further investigate the structural and functional impact of Leu100Pro, we structurally characterized the consequences of this change on the interaction of SPRED2 with neurofibromin, by 1 µn-long molecular dynamics (MD) simulations. Our analyses failed in identifying local perturbations predicted to disrupt or dramatically affect SPRED2 binding to neurofibromin, though a rearrangement of their interaction was observed. On the other hand, MD simulations also identified long-range structural rearrangements of the SPRED2 EVH-1 domain, which might be relevant for an aberrant folding of the mutant driving the previously documented accelerated degradation. Overall, the performed MD simulations suggest the occurrence of multiple intramolecular and intermolecular structural perturbations driven by the Leu100Pro change that likely contribute to its LoF behavior.

Indexed as

Molecular Dynamics SimulationNeurofibromin 1Amino Acid SubstitutionHumansProtein BindingProtein DomainsNeurofibromin 1essential dynamicsmolecular dynamicsneurofibromatosis type INoonan syndromeRAS signalingsprouty-related EVH-1 domain-containing

Identifiers

PMID40362579
PMCPMC12072562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.